purchase date indicated in Share Sale and Purchase Agreement . 4. The details of assets purchased 4.1 Nature of business At-Ze established in 2011 and operated business Original Equipment Manufacturer or OEM
established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be
shares Company’s name Aesthetic Zecret (At-Ze) Co., Ltd. Business type At-Ze established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and
National Stock Exchanges of India Limited (NSE) and the Bombay Stock Exchange Limited (BSE) and is the leading manufacturer of a wide range of polyester products in India. The current major shareholders of
Chaowanantakul 5) Mr. Peerayot Rujitess 6) Mr. Thaitawat Indratula Business Type Core business is manufacturer and distributor of Busduct which is high capacity conductors for power supply in buildings and
well as improved service for existing customer base; and more credibility by switching from a distributor to a manufacturer 2. Create opportunity to increase production capability to shorten lead time
Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Business DOD operates as a manufacturer of dietary supplement products under and customers' brand and its brand
ready to eat foods in convenience stores and modern trade outlets as well as original equipment manufacturer (OEMs)’s products. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) In Q3
Asian and The Middle East zones increased by Baht 29 million or increased by 12% from increased in Saudi Arabia customers. During the first quarter of 2020, many manufacturer countries have been facing
, and Africa zone dropped by Baht 83 million or 34%, Baht 46 million or 56% and Baht 11 million or 24%, respectively as many manufacturer countries have been facing the outbreak of Coronavirus (COVID- 19